Stockholder Notice: Robbins LLP Informs Stockholders of the Class Action Filed Against Orthofix Medical Inc.

Group 1 - The article reports that a class action has been filed against Orthofix Medical Inc. on behalf of shareholders who purchased stock between October 11, 2022, and September 12, 2023 [1] - The allegations state that Orthofix's management misled investors about their commitment to ethical standards and corporate values, while in reality, they engaged in inappropriate conduct [2] - Following the announcement of the termination of key executives, the company's stock price dropped by $5.62, or over 30%, closing at $13.01 per share on September 13, 2023 [2] Group 2 - Shareholders interested in participating as lead plaintiffs must submit their applications by October 21, 2024, and can remain absent class members if they choose not to participate [2] - Robbins LLP, the law firm handling the case, has a history of recovering over $1 billion for shareholders and focuses on holding company executives accountable [4]